(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are Datadog, MicroVision, and Aware, Inc..

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Datadog (DDOG) 131.04 14.02% 2021-08-05 07:11:53
2 MicroVision (MVIS) 13.81 13.01% 2021-08-05 07:09:46
3 Aware, Inc. (AWRE) 4.55 11.52% 2021-08-05 04:07:28
4 MercadoLibre (MELI) 1670.00 6.37% 2021-08-05 07:09:35
5 Electronic Arts (EA) 145.80 4.21% 2021-08-05 07:08:08
6 Booking Holdings (BKNG) 2157.00 3.42% 2021-08-05 07:11:36
7 Novavax (NVAX) 230.00 2.77% 2021-08-05 07:09:58
8 Novo Nordisk A/S (NVO) 100.85 2.69% 2021-08-05 06:16:03
9 Amicus Therapeutics (FOLD) 9.90 2.27% 2021-08-05 07:08:38
10 Regeneron Pharmaceuticals (REGN) 593.90 2.23% 2021-08-05 07:10:19

The three most active and biggest losers today are Etsy, Roku, and NetEase.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Etsy (ETSY) 175.32 -13.25% 2021-08-05 07:12:04
2 Roku (ROKU) 388.76 -7.51% 2021-08-05 07:12:50
3 NetEase (NTES) 88.76 -4.58% 2021-08-05 07:09:54
4 10x Genomics (TXG) 177.00 -4.23% 2021-08-05 07:13:09
5 Cigna (CI) 222.49 -3.88% 2021-08-05 07:14:23
6 Moderna (MRNA) 403.00 -3.83% 2021-08-05 07:12:28
7 Rio Tinto (RIO) 85.48 -3.45% 2021-08-05 07:16:41
8 IAC/InterActiveCorp (IAC) 129.99 -3.17% 2021-08-05 07:12:11
9 MicroStrategy (MSTR) 650.00 -3.12% 2021-08-05 07:09:42
10 Marathon (MARA) 27.96 -2.65% 2021-08-05 07:09:32

Most Active Premarket Winners today

1. Datadog (DDOG) – Premarket: 14.02%

NASDAQ Composite ended the session with Datadog jumping 0.22% to $114.93 on Thursday, following the last session’s upward trend. NASDAQ Composite rose 0.13% to $14,780.53, after three successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Datadog is 2666600, 3.11% above its average volume of 2586280.

Datadog’s Sales

Datadog’s sales growth is 56.9% for the ongoing quarter and 56.7% for the next. The company’s growth estimates for the present quarter and the next is a negative 40% and a negative 40%, respectively.

Volatility

Datadog’s last week, last month’s, and last quarter’s current volatility was 0.28%, 0.20%, and 1.85%, respectively.

Datadog’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.02% (last week), 1.23% (last month), and 1.85% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Datadog’s stock is considered to be oversold (<=20).

More news about Datadog.

2. MicroVision (MVIS) – Premarket: 13.01%

NASDAQ Composite ended the session with MicroVision falling 2% to $12.22 on Thursday, after four sequential sessions in a row of losses. NASDAQ Composite jumped 0.13% to $14,780.53, after three consecutive sessions in a row of gains, on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for MicroVision is 3837340, 67.35% below its average volume of 11752100.

MicroVision’s last close was $12.47, 55.46% under its 52-week high of $28.00.

News about MicroVision today

Why microvision shares shot up 15% today. According to today’s article on Business Insider, "Why It Matters: MicroVision is a favorite Reddit stock and was the tenth-most discussed stock on Reddit’s r/WallStreetBets forum as of Wednesday night.", "What Happened: MicroVision on Wednesday reported better-than-expected results for the second quarter."

The company’s growth estimates for the current quarter and the next is a negative 150% and a negative 100%, respectively.

MicroVision’s Revenue

Year-on-year quarterly revenue growth declined by 67.4%, now sitting on 2.1M for the twelve trailing months.

Volatility

MicroVision’s last week, last month’s, and last quarter’s current volatility was a positive 0.14%, a negative 1.31%, and a positive 5.22%, respectively.

MicroVision’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.90% (last week), 3.58% (last month), and 5.22% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

MicroVision’s stock is considered to be overbought (>=80).

MicroVision’s Stock Yearly Top and Bottom Value

MicroVision’s stock is valued at $12.22 at 08:34 EST, way under its 52-week high of $28.00 and way higher than its 52-week low of $1.25.

MicroVision’s Moving Average

MicroVision’s worth is way below its 50-day moving average of $15.88 and way under its 200-day moving average of $15.14.

More news about MicroVision.

3. Aware, Inc. (AWRE) – Premarket: 11.52%

NASDAQ Composite ended the session with Aware, Inc. sliding 0.24% to $4.08 on Thursday, after three successive sessions in a row of gains. NASDAQ Composite jumped 0.13% to $14,780.53, after three successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for Aware, Inc. is 37426, 20.06% below its average volume of 46818.

Aware, Inc.’s last close was $4.09, 37.27% below its 52-week high of $6.52.

Aware, Inc.’s Revenue

Year-on-year quarterly revenue growth grew by 25.6%, now sitting on 12.21M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Aware, Inc.’s stock is considered to be oversold (<=20).

Aware, Inc.’s Stock Yearly Top and Bottom Value

Aware, Inc.’s stock is valued at $4.08 at 08:34 EST, way under its 52-week high of $6.52 and way above its 52-week low of $2.54.

Aware, Inc.’s Moving Average

Aware, Inc.’s worth is above its 50-day moving average of $3.75 and above its 200-day moving average of $3.92.

More news about Aware, Inc..

4. MercadoLibre (MELI) – Premarket: 6.37%

NASDAQ Composite ended the session with MercadoLibre dropping 0.36% to $1,570.00 on Thursday while NASDAQ Composite jumped 0.13% to $14,780.53.

Volume

Today’s last reported volume for MercadoLibre is 241924, 38.82% below its average volume of 395440.

MercadoLibre’s last close was $1,575.70, 22% below its 52-week high of $2,020.00.

MercadoLibre’s Sales

MercadoLibre’s sales growth is 92.5% for the ongoing quarter and 70.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 90.1% and positive 7.1% for the next.

MercadoLibre’s Revenue

Year-on-year quarterly revenue growth grew by 111.4%, now sitting on 4.7B for the twelve trailing months.

Volatility

MercadoLibre’s last week, last month’s, and last quarter’s current volatility was 0.73%, 0.17%, and 1.53%, respectively.

MercadoLibre’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.79% (last week), 1.37% (last month), and 1.53% (last quarter), respectively.

MercadoLibre’s Stock Yearly Top and Bottom Value

MercadoLibre’s stock is valued at $1,570.00 at 08:34 EST, way below its 52-week high of $2,020.00 and way higher than its 52-week low of $959.87.

MercadoLibre’s Moving Average

MercadoLibre’s worth is higher than its 50-day moving average of $1,540.29 and above its 200-day moving average of $1,566.24.

More news about MercadoLibre.

5. Electronic Arts (EA) – Premarket: 4.21%

NASDAQ Composite ended the session with Electronic Arts rising 0.08% to $139.91 on Thursday, following the last session’s downward trend. NASDAQ Composite jumped 0.13% to $14,780.53, after three sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Electronic Arts is 2677030, 22.5% above its average volume of 2185260.

Electronic Arts’s last close was $139.80, 6.99% under its 52-week high of $150.30.

The company’s growth estimates for the present quarter is a negative 56.3% and positive 2040% for the next.

Electronic Arts’s Revenue

Year-on-year quarterly revenue growth grew by 5%, now sitting on 5.67B for the twelve trailing months.

Volatility

Electronic Arts’s last week, last month’s, and last quarter’s current volatility was a positive 0.22%, a negative 0.02%, and a positive 0.93%, respectively.

Electronic Arts’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.39% (last week), 0.77% (last month), and 0.93% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Electronic Arts’s stock is considered to be overbought (>=80).

Electronic Arts’s Stock Yearly Top and Bottom Value

Electronic Arts’s stock is valued at $139.91 at 08:34 EST, below its 52-week high of $150.30 and way higher than its 52-week low of $110.15.

Electronic Arts’s Moving Average

Electronic Arts’s worth is below its 50-day moving average of $142.22 and below its 200-day moving average of $140.68.

More news about Electronic Arts.

6. Booking Holdings (BKNG) – Premarket: 3.42%

NASDAQ Composite ended the session with Booking Holdings dropping 2.51% to $2,085.64 on Thursday, after four consecutive sessions in a row of losses. NASDAQ Composite jumped 0.13% to $14,780.53, after three consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Booking Holdings is 369125, 20.24% above its average volume of 306998.

Booking Holdings’s last close was $2,139.29, 14.97% below its 52-week high of $2,516.00.

Booking Holdings’s Sales

Booking Holdings’s sales growth is 205% for the ongoing quarter and 42% for the next. The company’s growth estimates for the ongoing quarter and the next is 85.4% and 114.3%, respectively.

Booking Holdings’s Revenue

Year-on-year quarterly revenue growth declined by 50.1%, now sitting on 5.65B for the twelve trailing months.

Volatility

Booking Holdings’s last week, last month’s, and last quarter’s current volatility was 0.36%, 0.12%, and 1.27%, respectively.

Booking Holdings’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.81% (last week), 1.20% (last month), and 1.27% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Booking Holdings’s stock is considered to be overbought (>=80).

Booking Holdings’s Stock Yearly Top and Bottom Value

Booking Holdings’s stock is valued at $2,085.64 at 08:34 EST, way under its 52-week high of $2,516.00 and way higher than its 52-week low of $1,589.00.

Booking Holdings’s Moving Average

Booking Holdings’s worth is under its 50-day moving average of $2,207.57 and under its 200-day moving average of $2,268.45.

Previous days news about Booking Holdings

Booking holdings to make second quarter 2021 earnings press release available on company’s investor relations website on Wednesday, August 4. According to PRNewsWire on Tuesday, 3 August, "Second quarter 2021 financial results for Booking Holdings (NASDAQ: BKNG) will be made available at approximately 4:00 p.m. ", "The mission of Booking Holdings is to make it easier for everyone to experience the world. "

Booking holdings to make second quarter 2021 earnings press release available on company's investor relations website on Wednesday, August 4. According to Business Insider on Wednesday, 4 August, "Second quarter 2021 financial results for Booking Holdings (NASDAQ: BKNG) will be made available at approximately 4:00 p.m. ", "The mission of Booking Holdings is to make it easier for everyone to experience the world. "

More news about Booking Holdings.

7. Novavax (NVAX) – Premarket: 2.77%

NASDAQ Composite ended the session with Novavax rising 18.69% to $223.81 on Thursday, after two sequential sessions in a row of gains. NASDAQ Composite jumped 0.13% to $14,780.53, after three consecutive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Novavax is 14255300, 250.26% above its average volume of 4069890.

Novavax’s last close was $188.57, 43.15% below its 52-week high of $331.68.

The company’s growth estimates for the current quarter is a negative 1110% and positive 12.1% for the next.

Novavax’s Revenue

Year-on-year quarterly revenue growth grew by 13143.4%, now sitting on 919.45M for the twelve trailing months.

Volatility

Novavax’s last week, last month’s, and last quarter’s current volatility was a negative 2.70%, a negative 0.54%, and a positive 4.42%, respectively.

Novavax’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.50% (last week), 3.61% (last month), and 4.42% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Novavax’s stock is considered to be oversold (<=20).

Novavax’s Stock Yearly Top and Bottom Value

Novavax’s stock is valued at $223.81 at 08:34 EST, way below its 52-week high of $331.68 and way above its 52-week low of $76.59.

Novavax’s Moving Average

Novavax’s worth is way higher than its 50-day moving average of $192.82 and way above its 200-day moving average of $196.62.

More news about Novavax.

8. Novo Nordisk A/S (NVO) – Premarket: 2.69%

NYSE Composite ended the session with Novo Nordisk A/S rising 5.47% to $98.21 on Thursday, following the last session’s upward trend. NYSE Composite fell 0.5% to $16,629.50, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Novo Nordisk A/S is 3110340, 237.55% above its average volume of 921434.

Novo Nordisk A/S’s last close was $92.60, 0.46% above its 52-week high of $92.18.

Novo Nordisk A/S’s Sales

Novo Nordisk A/S’s sales growth is 8.1% for the current quarter and 7.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 6.9% and 5.6%, respectively.

Novo Nordisk A/S’s Revenue

Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 126.88B for the twelve trailing months.

Volatility

Novo Nordisk A/S’s last week, last month’s, and last quarter’s current volatility was 0.92%, 0.44%, and 0.86%, respectively.

Novo Nordisk A/S’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.75% (last week), 0.88% (last month), and 0.86% (last quarter), respectively.

Novo Nordisk A/S’s Stock Yearly Top and Bottom Value

Novo Nordisk A/S’s stock is valued at $98.21 at 08:34 EST, above its 52-week high of $92.18.

Novo Nordisk A/S’s Moving Average

Novo Nordisk A/S’s worth is way above its 50-day moving average of $85.13 and way above its 200-day moving average of $76.14.

More news about Novo Nordisk A/S.

9. Amicus Therapeutics (FOLD) – Premarket: 2.27%

NASDAQ Composite ended the session with Amicus Therapeutics rising 3.75% to $9.68 on Thursday, following the last session’s upward trend. NASDAQ Composite rose 0.13% to $14,780.53, after three successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Amicus Therapeutics is 3428380, 41.73% above its average volume of 2418930.

Amicus Therapeutics’s last close was $9.33, 63.25% below its 52-week high of $25.39.

The company’s growth estimates for the present quarter is a negative 10% and positive 16% for the next.

Amicus Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 9.7%, now sitting on 266.76M for the twelve trailing months.

Volatility

Amicus Therapeutics’s last week, last month’s, and last quarter’s current volatility was a positive 1.17%, a negative 0.52%, and a positive 2.27%, respectively.

Amicus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.17% (last week), 2.45% (last month), and 2.27% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Amicus Therapeutics’s stock is considered to be oversold (<=20).

Amicus Therapeutics’s Stock Yearly Top and Bottom Value

Amicus Therapeutics’s stock is valued at $9.68 at 08:34 EST, way under its 52-week high of $25.39 and way higher than its 52-week low of $8.60.

Amicus Therapeutics’s Moving Average

Amicus Therapeutics’s value is above its 50-day moving average of $9.53 and way below its 200-day moving average of $11.27.

More news about Amicus Therapeutics.

10. Regeneron Pharmaceuticals (REGN) – Premarket: 2.23%

NASDAQ Composite ended the session with Regeneron Pharmaceuticals falling 0.95% to $580.95 on Thursday, following the last session’s upward trend. NASDAQ Composite rose 0.13% to $14,780.53, after three successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Regeneron Pharmaceuticals is 1027200, 39.25% above its average volume of 737653.

Regeneron Pharmaceuticals’s last close was $586.51, 11.13% below its 52-week high of $660.00.

The company’s growth estimates for the current quarter and the next is 150.3% and 21.9%, respectively.

Regeneron Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 38.3%, now sitting on 9.01B for the twelve trailing months.

Volatility

Regeneron Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a negative 0.02%, a positive 0.36%, and a positive 1.04%, respectively.

Regeneron Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.77% (last week), 1.01% (last month), and 1.04% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Regeneron Pharmaceuticals’s stock is considered to be oversold (<=20).

Regeneron Pharmaceuticals’s Stock Yearly Top and Bottom Value

Regeneron Pharmaceuticals’s stock is valued at $580.95 at 08:34 EST, way below its 52-week high of $660.00 and way higher than its 52-week low of $441.00.

Regeneron Pharmaceuticals’s Moving Average

Regeneron Pharmaceuticals’s value is higher than its 50-day moving average of $567.08 and way above its 200-day moving average of $511.14.

More news about Regeneron Pharmaceuticals.

Most Active Premarket Losers Today

1. Etsy (ETSY) – Premarket: -13.25%

NASDAQ Composite ended the session with Etsy jumping 6.11% to $202.10 on Thursday, after two successive sessions in a row of gains. NASDAQ Composite rose 0.13% to $14,780.53, after three consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for Etsy is 4812320, 57.75% above its average volume of 3050570.

Etsy’s last close was $190.46, 24.38% below its 52-week high of $251.86.

The company’s growth estimates for the ongoing quarter and the next is a negative 17.3% and a negative 12.9%, respectively.

Etsy’s Revenue

Year-on-year quarterly revenue growth grew by 141.5%, now sitting on 2.05B for the twelve trailing months.

Volatility

Etsy’s last week, last month’s, and last quarter’s current volatility was 0.14%, 0.01%, and 2.41%, respectively.

Etsy’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.46% (last week), 1.88% (last month), and 2.41% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Etsy’s stock is considered to be oversold (<=20).

Etsy’s Stock Yearly Top and Bottom Value

Etsy’s stock is valued at $202.10 at 08:34 EST, way below its 52-week high of $251.86 and way higher than its 52-week low of $103.06.

Etsy’s Moving Average

Etsy’s worth is above its 50-day moving average of $189.37 and higher than its 200-day moving average of $197.45.

Previous days news about Etsy

Etsy plummets on revenue guidance. According to Benzinga on Wednesday, 4 August, "What Happened: Etsy reported second-quarter revenue of $528.9 million, up 23.4% year-over-year. ", "What’s Next: Etsy is guiding for third-quarter revenue to come in a range of $500 million to $525 million. "

More news about Etsy.

2. Roku (ROKU) – Premarket: -7.51%

NASDAQ Composite ended the session with Roku rising 0.6% to $420.32 on Thursday, after four sequential sessions in a row of losses. NASDAQ Composite rose 0.13% to $14,780.53, after three consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Roku is 3018180, 33.38% below its average volume of 4530330.

Roku’s last close was $417.80, 14.87% under its 52-week high of $490.76.

News about Roku today

Roku pays to be a player. According to today’s article on The Wall Street Journal, "Investors got a painful reminder Wednesday that Roku is still in the hardware business.", "Streaming hours over the Roku platform also slipped 5% from the first quarter-the first sequential decline for this metric on record."

Roku’s Sales

Roku’s sales growth is 96.1% for the present quarter and 75.4% for the next. The company’s growth estimates for the present quarter is 134.3% and a drop 333.3% for the next.

Roku’s Revenue

Year-on-year quarterly revenue growth grew by 79%, now sitting on 2.03B for the twelve trailing months.

Volatility

Roku’s last week, last month’s, and last quarter’s current volatility was 2.85%, 0.33%, and 2.88%, respectively.

Roku’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.04% (last week), 2.67% (last month), and 2.88% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Roku’s stock is considered to be overbought (>=80).

Roku’s Stock Yearly Top and Bottom Value

Roku’s stock is valued at $420.32 at 08:34 EST, way below its 52-week high of $490.76 and way higher than its 52-week low of $143.21.

Roku’s Moving Average

Roku’s worth is above its 50-day moving average of $418.90 and way higher than its 200-day moving average of $381.26.

Previous days news about Roku

Why did Roku stock drop 10% in A week?. According to Forbes on Tuesday, 3 August, "If you buy and hold Roku stock, the expectation is over time the near-term fluctuations will cancel out, and the long-term positive trend will favor you – at least if the company is otherwise strong.", "Try the Trefis machine learning engine above to see for yourself how Roku stock is likely to behave after any specific gain or loss over a period."

Roku earnings: what to look for. According to Investopedia on Tuesday, 3 August, "It also means more recurring subscription revenue and more people buying and replacing Roku products as they age or break.", "Encouragingly, Roku has reversed that trend since Q3 FY 2020, posting positive EPS that rapidly accelerated on a sequential basis. "

Roku slides as reopening leads to less streaming viewing. According to Bloomberg Quint on Wednesday, 4 August, "For the second quarter, Roku revenue came in at $645.1 million, above the $613.1 million estimate.", "Shares of Roku are down about 12% from a record close hit in July, though it remains up nearly 50% from a May low, based on its most recent close. "

More news about Roku.

3. NetEase (NTES) – Premarket: -4.58%

NASDAQ Composite ended the session with NetEase dropping 0.04% to $93.02 on Thursday while NASDAQ Composite rose 0.13% to $14,780.53.

Volume

Today’s last reported volume for NetEase is 3501040, 34.92% above its average volume of 2594850.

NetEase’s last close was $93.06, 30.72% under its 52-week high of $134.33.

NetEase’s Sales

NetEase’s sales growth is 13.8% for the ongoing quarter and 20.4% for the next. The company’s growth estimates for the present quarter is a negative 21.3% and positive 19.5% for the next.

NetEase’s Revenue

Year-on-year quarterly revenue growth grew by 20.2%, now sitting on 77.12B for the twelve trailing months.

Volatility

NetEase’s last week, last month’s, and last quarter’s current volatility was a negative 3.09%, a negative 0.72%, and a positive 2.24%, respectively.

NetEase’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 9.78% (last week), 3.03% (last month), and 2.24% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

NetEase’s stock is considered to be overbought (>=80).

NetEase’s Stock Yearly Top and Bottom Value

NetEase’s stock is valued at $93.02 at 08:34 EST, way under its 52-week high of $134.33 and way above its 52-week low of $82.50.

NetEase’s Moving Average

NetEase’s value is way under its 50-day moving average of $107.61 and way under its 200-day moving average of $111.17.

More news about NetEase.

4. 10x Genomics (TXG) – Premarket: -4.23%

NASDAQ Composite ended the session with 10x Genomics jumping 3.51% to $184.82 on Thursday while NASDAQ Composite rose 0.13% to $14,780.53.

Volume

Today’s last reported volume for 10x Genomics is 599157, 27.87% below its average volume of 830668.

10x Genomics’s last close was $178.55, 14.57% below its 52-week high of $208.99.

The company’s growth estimates for the current quarter and the next is 36.6% and 69.2%, respectively.

10x Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 47.2%, now sitting on 332.76M for the twelve trailing months.

Volatility

10x Genomics’s last week, last month’s, and last quarter’s current volatility was a positive 0.16%, a negative 0.38%, and a positive 2.69%, respectively.

10x Genomics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.91% (last week), 2.17% (last month), and 2.69% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

10x Genomics’s stock is considered to be overbought (>=80).

10x Genomics’s Stock Yearly Top and Bottom Value

10x Genomics’s stock is valued at $184.82 at 08:34 EST, way under its 52-week high of $208.99 and way above its 52-week low of $92.54.

10x Genomics’s Moving Average

10x Genomics’s worth is below its 50-day moving average of $187.68 and above its 200-day moving average of $178.97.

More news about 10x Genomics.

5. Cigna (CI) – Premarket: -3.88%

NYSE Composite ended the session with Cigna dropping 1.06% to $231.48 on Thursday while NYSE Composite slid 0.5% to $16,629.50.

Volume

Today’s last reported volume for Cigna is 1718290, 2.39% below its average volume of 1760320.

Cigna’s last close was $233.96, 14.24% under its 52-week high of $272.81.

News about Cigna today

Cigna corp. Q2 adjusted earnings beat estimates. According to today’s article on Business Insider, "Excluding items, Cigna Corp. reported adjusted earnings of $1.81 billion or $5.24 per share for the period."

Cigna beats earnings expectations and raises revenue outlook, but stock falls. According to today’s article on MarketWatch, "For 2021, Cigna raised its revenue outlook to at least $170 billion from at least $166 billion, and affirmed its adjusted EPS outlook of at least $20.20."

The company’s growth estimates for the present quarter is a negative 14.6% and positive 25.4% for the next.

Cigna’s Revenue

Year-on-year quarterly revenue growth grew by 6.8%, now sitting on 163.14B for the twelve trailing months.

Volatility

Cigna’s last week, last month’s, and last quarter’s current volatility was a negative 0.55%, a negative 0.21%, and a positive 0.92%, respectively.

Cigna’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.78% (last week), 0.81% (last month), and 0.92% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Cigna’s stock is considered to be oversold (<=20).

Cigna’s Stock Yearly Top and Bottom Value

Cigna’s stock is valued at $231.48 at 08:34 EST, way under its 52-week high of $272.81 and way higher than its 52-week low of $158.84.

Cigna’s Moving Average

Cigna’s worth is below its 50-day moving average of $234.30 and under its 200-day moving average of $237.30.

More news about Cigna.

6. Moderna (MRNA) – Premarket: -3.83%

NASDAQ Composite ended the session with Moderna rising 8.42% to $419.05 on Thursday, following the last session’s upward trend. NASDAQ Composite rose 0.13% to $14,780.53, after three successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Moderna is 31901200, 144.76% above its average volume of 13033500.

Moderna’s last close was $386.51, 6.77% higher than its 52-week high of $362.00.

News about Moderna today

Moderna shot’s protection against covid stays steady for months. According to today’s article on Bloomberg Quint, "Cambridge, Massachusetts-based Moderna also said it expected to complete its submission for full Food and Drug Administration approval for its vaccine this month.", "Despite the apparent endurance of its vaccine, Moderna is exploring options for supplemental shots that could fend off emerging strains of the virus."

Robinhood remains top wallstreetbets interest by far as stock surges 50% — AMD, amc, Moderna other top trends. According to today’s article on Benzinga, "Robinhood Markets Inc. (NASDAQ:HOOD) continues to be the most-discussed stock on Reddit’s r/WallStreetBets forum as of Wednesday night, while Advanced Micro Devices Inc. (NASDAQ:AMD), AMC Entertainment Holdings Inc. (NYSE:AMC) and Moderna Inc. (NASDAQ:MRNA) are also seeing high interest."

Moderna earnings topped expectations. why its stock is dropping.. According to today’s article on Barrons, "I am proud of the progress our teams at Moderna have made in the past quarter in advancing our development pipeline while addressing a global pandemic and quickly establishing global manufacturing and commercial organizations," Stéphane Bancel, Moderna’s CEO, said in a press release.", "Shares of Moderna had dropped 0.5% to $417.02 in premarket trading Thursday, which should probably be considered a victory after it gained 141% over the past three months as Covid worries have built again."

Moderna’s Sales

Moderna’s sales growth is 6347.1% for the present quarter and 7189.7% for the next. The company’s growth estimates for the current quarter and the next is 2048.4% and 1439%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 24112.5%, now sitting on 2.73B for the twelve trailing months.

Volatility

Moderna’s last week, last month’s, and last quarter’s current volatility was 2.02%, 2.08%, and 3.24%, respectively.

Moderna’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.07% (last week), 3.66% (last month), and 3.24% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Moderna’s stock is considered to be oversold (<=20).

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $419.05 at 08:34 EST, way above its 52-week high of $362.00.

Moderna’s Moving Average

Moderna’s worth is way above its 50-day moving average of $257.86 and way higher than its 200-day moving average of $183.99.

Previous days news about Moderna

Moderna and biontech stocks are surging amid reports of FDA vaccine-approval progress. According to Business Insider on Wednesday, 4 August, "BioNTech, a Nasdaq-listed German company, jumped as much as 19% to $417.22, while Moderna extended its two-day rise to 23%, hitting an intraday high of $427. ", "As the Delta variant has ramped up, a report from Vanda Research on Wednesday showed trading volume in Moderna and Pfizer being driven by retail investors, with $180 million in retail cash flowing into the two companies over the last 10 days."

More news about Moderna.

7. Rio Tinto (RIO) – Premarket: -3.45%

NYSE Composite ended the session with Rio Tinto dropping 0.96% to $88.53 on Thursday while NYSE Composite slid 0.5% to $16,629.50.

Volume

Today’s last reported volume for Rio Tinto is 1890130, 21.23% below its average volume of 2399410.

Rio Tinto’s last close was $86.31, 10.07% below its 52-week high of $95.97.

Rio Tinto’s Revenue

Year-on-year quarterly revenue growth grew by 12.5%, now sitting on 44.61B for the twelve trailing months.

Volatility

Rio Tinto’s last week, last month’s, and last quarter’s current volatility was 1.37%, 0.12%, and 1.68%, respectively.

Rio Tinto’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.35% (last week), 2.05% (last month), and 1.68% (last quarter), respectively.

Rio Tinto’s Stock Yearly Top and Bottom Value

Rio Tinto’s stock is valued at $88.53 at 08:34 EST, below its 52-week high of $95.97 and way higher than its 52-week low of $55.39.

Rio Tinto’s Moving Average

Rio Tinto’s value is above its 50-day moving average of $84.43 and above its 200-day moving average of $84.06.

More news about Rio Tinto.

8. IAC/InterActiveCorp (IAC) – Premarket: -3.17%

NASDAQ Composite ended the session with IAC/InterActiveCorp sliding 0.38% to $134.25 on Thursday while NASDAQ Composite jumped 0.13% to $14,780.53.

Volume

Today’s last reported volume for IAC/InterActiveCorp is 375869, 54.83% below its average volume of 832097.

IAC/InterActiveCorp’s last close was $134.76, 24.77% under its 52-week high of $179.12.

IAC/InterActiveCorp’s Sales

IAC/InterActiveCorp’s sales growth is 24.3% for the ongoing quarter and 22.9% for the next. The company’s growth estimates for the current quarter is 51.3% and a drop 124.5% for the next.

IAC/InterActiveCorp’s Revenue

Year-on-year quarterly revenue growth grew by 28%, now sitting on 3.24B for the twelve trailing months.

Volatility

IAC/InterActiveCorp’s last week, last month’s, and last quarter’s current volatility was a positive 0.01%, a negative 0.63%, and a positive 2.01%, respectively.

IAC/InterActiveCorp’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.55% (last week), 1.59% (last month), and 2.01% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

IAC/InterActiveCorp’s stock is considered to be overbought (>=80).

IAC/InterActiveCorp’s Stock Yearly Top and Bottom Value

IAC/InterActiveCorp’s stock is valued at $134.25 at 08:34 EST, way under its 52-week high of $179.12 and way above its 52-week low of $74.52.

IAC/InterActiveCorp’s Moving Average

IAC/InterActiveCorp’s value is below its 50-day moving average of $145.12 and way under its 200-day moving average of $154.24.

More news about IAC/InterActiveCorp.

9. MicroStrategy (MSTR) – Premarket: -3.12%

NASDAQ Composite ended the session with MicroStrategy jumping 7.34% to $670.93 on Thursday while NASDAQ Composite jumped 0.13% to $14,780.53.

Volume

Today’s last reported volume for MicroStrategy is 916959, 9.54% above its average volume of 837115.

MicroStrategy’s last close was $625.06, 52.47% under its 52-week high of $1,315.00.

The company’s growth estimates for the current quarter and the next is 194.3% and 208.8%, respectively.

MicroStrategy’s Revenue

Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 492.21M for the twelve trailing months.

Volatility

MicroStrategy’s last week, last month’s, and last quarter’s current volatility was a positive 4.44%, a negative 0.04%, and a positive 4.43%, respectively.

MicroStrategy’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 10.06% (last week), 4.35% (last month), and 4.43% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

MicroStrategy’s stock is considered to be overbought (>=80).

MicroStrategy’s Stock Yearly Top and Bottom Value

MicroStrategy’s stock is valued at $670.93 at 08:34 EST, way below its 52-week high of $1,315.00 and way above its 52-week low of $122.15.

MicroStrategy’s Moving Average

MicroStrategy’s worth is way higher than its 50-day moving average of $601.01 and above its 200-day moving average of $649.22.

More news about MicroStrategy.

10. Marathon (MARA) – Premarket: -2.65%

NASDAQ Composite ended the session with Marathon rising 5.86% to $28.72 on Thursday while NASDAQ Composite rose 0.13% to $14,780.53.

Volume

Today’s last reported volume for Marathon is 7599410, 39.5% below its average volume of 12561500.

Marathon’s last close was $27.13, 53.02% under its 52-week high of $57.75.

Marathon’s Revenue

Year-on-year quarterly revenue growth grew by 1444.8%, now sitting on 12.92M for the twelve trailing months.

Volatility

Marathon’s last week, last month’s, and last quarter’s current volatility was a positive 3.07%, a negative 0.56%, and a positive 4.84%, respectively.

Marathon’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 9.07% (last week), 4.26% (last month), and 4.84% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Marathon’s stock is considered to be overbought (>=80).

Marathon’s Stock Yearly Top and Bottom Value

Marathon’s stock is valued at $28.72 at 08:34 EST, way under its 52-week high of $57.75 and way above its 52-week low of $1.48.

Marathon’s Moving Average

Marathon’s value is higher than its 50-day moving average of $27.69 and below its 200-day moving average of $31.35.

More news about Marathon.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here